Search - tctmd.com

Displaying 21 - 40 of 81

Sort: Relevancy | Date

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Yael L. Maxwell

January 13, 2021

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

News Opinion CV Team Dispatch

April 2020 News Roundup

L.A. McKeown

April 10, 2020

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Daily News

Elderly Women Worse Off Than Men Before and After Acute MI

Yael L. Maxwell

October 22, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

Presentation SIF 2019

DEBATE:What is the Optimal Choice for Post PCI Patients Requiring Chronic Anticoaguation :Triple Therapy

Presenter: Michael A. Kutcher

March 29, 2019

Advertisement

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Observational Study Supports Continuing Oral Anticoagulation During PCI

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

April 2020 News Roundup

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Elderly Women Worse Off Than Men Before and After Acute MI

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

TCTMD’s Top 10 Most Popular Stories for June 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

New Clarity on Patients at High Risk for Bleeding After PCI

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

DEBATE:What is the Optimal Choice for Post PCI Patients Requiring Chronic Anticoaguation :Triple Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content